Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mathilde Varret

Showing results (41-50 of 55) with videos related to

Pageof 6
Sort By:
Atherosclerosis|June 12, 2012
Identification and characterization of new gain-of-function mutations in the PCSK9 gene responsible for autosomal dominant hypercholesterolemiaMarianne Abifadel, Maryse Guerin, Suzanne Benjannet, et al.
Diabetes, Obesity & Metabolism|December 6, 2017
Plasma proprotein-convertase-subtilisin/kexin type 9 (PCSK9) and cardiovascular events in type 2 diabetesPetra El Khoury, Ronan Roussel, Frederic Fumeron, et al.
Archives of Cardiovascular Diseases|November 29, 2021
Lipoprotein(a): Pathophysiology, measurement, indication and treatment in cardiovascular disease. A consensus statement from the Nouvelle Société Francophone d'Athérosclérose (NSFA)Vincent Durlach, Dominique Bonnefont-Rousselot, Franck Boccara, et al.
Nature Genetics|July 6, 2004
Heterozygous TGFBR2 mutations in Marfan syndromeTakeshi Mizuguchi, Gwenaëlle Collod-Beroud, Takushi Akiyama, et al.
Journal of Clinical Lipidology|August 7, 2023
Integrated omics approach for the identification of HDL structure-function relationships in PCSK9-related familial hypercholesterolemiaMaryam Darabi, Marie Lhomme, Maharajah Ponnaiah, et al.
American Journal of Human Genetics|December 1, 2014
MFAP5 loss-of-function mutations underscore the involvement of matrix alteration in the pathogenesis of familial thoracic aortic aneurysms and dissectionsMathieu Barbier, Marie-Sylvie Gross, Mélodie Aubart, et al.
Human Mutation|September 6, 2012
Description of a large family with autosomal dominant hypercholesterolemia associated with the APOE p.Leu167del mutationMarie Marduel, Khadija Ouguerram, Valérie Serre, et al.
Nature Genetics|May 6, 2003
Mutations in PCSK9 cause autosomal dominant hypercholesterolemiaMarianne Abifadel, Mathilde Varret, Jean-Pierre Rabès, et al.
Atherosclerosis|November 5, 2024
The singular French PCSK9-p.Ser127Arg gain-of-function variant: A significant player in cholesterol levels from a 775-year-old common ancestorYara Azar, Thomas E Ludwig, Hugo Le Bon, et al.
Nature Genetics|July 10, 2012
TGFB2 mutations cause familial thoracic aortic aneurysms and dissections associated with mild systemic features of Marfan syndromeCatherine Boileau, Dong-Chuan Guo, Nadine Hanna, et al.
Pageof 6

Showing results (41-50 of 55) with videos related to

Sort By:
Pageof 6
Atherosclerosis|June 12, 2012
Identification and characterization of new gain-of-function mutations in the PCSK9 gene responsible for autosomal dominant hypercholesterolemiaMarianne Abifadel, Maryse Guerin, Suzanne Benjannet, et al.
Diabetes, Obesity & Metabolism|December 6, 2017
Plasma proprotein-convertase-subtilisin/kexin type 9 (PCSK9) and cardiovascular events in type 2 diabetesPetra El Khoury, Ronan Roussel, Frederic Fumeron, et al.
Archives of Cardiovascular Diseases|November 29, 2021
Lipoprotein(a): Pathophysiology, measurement, indication and treatment in cardiovascular disease. A consensus statement from the Nouvelle Société Francophone d'Athérosclérose (NSFA)Vincent Durlach, Dominique Bonnefont-Rousselot, Franck Boccara, et al.
Nature Genetics|July 6, 2004
Heterozygous TGFBR2 mutations in Marfan syndromeTakeshi Mizuguchi, Gwenaëlle Collod-Beroud, Takushi Akiyama, et al.
Journal of Clinical Lipidology|August 7, 2023
Integrated omics approach for the identification of HDL structure-function relationships in PCSK9-related familial hypercholesterolemiaMaryam Darabi, Marie Lhomme, Maharajah Ponnaiah, et al.
American Journal of Human Genetics|December 1, 2014
MFAP5 loss-of-function mutations underscore the involvement of matrix alteration in the pathogenesis of familial thoracic aortic aneurysms and dissectionsMathieu Barbier, Marie-Sylvie Gross, Mélodie Aubart, et al.
Human Mutation|September 6, 2012
Description of a large family with autosomal dominant hypercholesterolemia associated with the APOE p.Leu167del mutationMarie Marduel, Khadija Ouguerram, Valérie Serre, et al.
Nature Genetics|May 6, 2003
Mutations in PCSK9 cause autosomal dominant hypercholesterolemiaMarianne Abifadel, Mathilde Varret, Jean-Pierre Rabès, et al.
Atherosclerosis|November 5, 2024
The singular French PCSK9-p.Ser127Arg gain-of-function variant: A significant player in cholesterol levels from a 775-year-old common ancestorYara Azar, Thomas E Ludwig, Hugo Le Bon, et al.
Nature Genetics|July 10, 2012
TGFB2 mutations cause familial thoracic aortic aneurysms and dissections associated with mild systemic features of Marfan syndromeCatherine Boileau, Dong-Chuan Guo, Nadine Hanna, et al.
Pageof 6